People who engage in binge eating, substance abuse and obsessive compulsive disorder all share a common pattern of decision making and similarities in brain structure, according to a  new paper in Molecular Psychiatry.

Many people, regardless of occupation, have experienced a difficult boss or annoying co-workers. It might even be harassment or bullying.

It's still better than being ignored, according to a paper in Organization Science. University of British Columbia scholars contend that while most consider ostracism less harmful than bullying, feeling excluded is significantly more likely to lead job dissatisfaction, quitting and health problems.

"We've been taught that ignoring someone is socially preferable--if you don't have something nice to say, don't say anything at all," says Professor Sandra Robinson, who co-authored the paper. "But ostracism actually leads people to feel more helpless, like they're not worthy of any attention at all." 

Psychological stress is harmful to sperm and semen quality, affecting its concentration, appearance, and ability to fertilize an egg, according to a study led by researchers Columbia University's Mailman School of Public Health and Rutgers School of Public Health. Results are published online in the journal Fertility and Sterility.

According to the American Society for Reproductive Medicine, infertility affects men and women equally, and semen quality is a key indicator of male fertility.

One of the nice details lost in the big picture of the Higgs boson discovery of 2012 is that a significant part of the signal put in evidence by ATLAS and CMS is produced by a very special kind of interactions between the protons accelerated by the LHC. These are "vector boson fusion" processes, whereby it is not the protons or its constituents that come in direct contact, but rather, each proton emits a W boson, and it is the latter pair which fuse together, give rise to a Higgs particle.

In the pop culture world of mainstream media, magic bullets are common. Every week there is a new miracle vegetable and then the following work there will be scare journalism about some chemical.

In the world of magic bullets, smoking causes lung cancer. Yet science knows that a risk factor is not genetic determinism. If lung cancer among non-smokers were itemized separately from smokers, it would be in the top 10 killers all on its own, and shockingly few smokers get lung cancer compared to the hundred million who are smoking just in America.

Do you prefer to own a DVD, rather than wondering if Netflix will remove whatever show you wanted to watch this week? If you buy or rent, rather than streaming, you are contributing to billions of tons of carbon going into the atmosphere.

Photographers like Richard Avedon, Diane Arbus, and Martin Schoeller made their reputations with distinctive visual styles that sometimes required the careful control of lighting possible only in the studio.

I may have once endorsed Eckhart Tolle by pointing out similarities between Tolle and Muho. Muho wrote to me that he does not know why his own meditative practice worked for him. In my eyes, such honesty and awareness about uncertainty are consistent with Zen. Tolle effectively* claims his way as the only true way for everybody.

(* "effectively" means that he does not claim so explicitly, but in effect, "effectively")

2.1 billion people, nearly 30% of the world's population, are overweight, according to a new analysis of data from 188 countries. 

In 1980, the world was still worried about doomsday prophets and a population bomb that would lead to mass starvation, wars over food, and a world government to mandate abortion; instead, agricultural science has grown so much more food that many poor people can afford to eat like royalty and get fat.

Cheap, plentiful food is a win for the world but now we have a major public health epidemic in both the developed and the developing world. 

A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug. In a correspondence published online May 28 in the New England Journal of Medicine, they show how the mutation triggers resistance. Their finding could guide development of new agents to treat drug-resistant disease.

Ibrutinib received accelerated approval from the Food and Drug Administration for use in chronic lymphocytic leukemia in February. It has revolutionized treatment, transforming CLL from a deadly disease to a chronic one. But about eight percent of patients develop resistance to this lifesaving drug.